Pro-inflammatory cytokines associate with NETosis during sickle cell vaso-occlusive crises.

[1]  A. Tselepis,et al.  The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis. , 2019, Atherosclerosis.

[2]  P. Kubes,et al.  Neutrophils and NETs in modulating acute and chronic inflammation. , 2019, Blood.

[3]  I. Fernández-Ruíz.  Inflammation: NETs are involved in AAA , 2018, Nature Reviews Cardiology.

[4]  K. Ataga,et al.  Crizanlizumab in Sickle Cell Disease. , 2017, The New England journal of medicine.

[5]  K. Ataga,et al.  Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease , 2017, The New England journal of medicine.

[6]  D. Wagner,et al.  Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. , 2014, Blood.

[7]  G. Solgi,et al.  Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition. , 2013, European cytokine network.

[8]  J. Hibbert,et al.  Elevated IL-1α and CXCL10 Serum Levels Occur in Patients with Homozygous Sickle Cell Disease and a History of Acute Splenic Sequestration , 2012, Disease markers.

[9]  S. Saad,et al.  Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy , 2009, Journal of leukocyte biology.

[10]  A. Varki,et al.  P-selectin mediates the adhesion of sickle erythrocytes to the endothelium. , 2001, Blood.

[11]  I. Okpala,et al.  Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA) , 1998, European journal of haematology.

[12]  S. Charache.  Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. , 1997, Seminars in hematology.

[13]  M L Terrin,et al.  Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent , 1996, Medicine.

[14]  R. Mitchell,et al.  Serum interleukin-6 levels in the steady state of sickle cell disease. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  O. Platt,et al.  Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.